Use of MPTP-Hemiparkinsonian (HP) Monkeys to Evaluate Efficacy of Tissue Implants as a Treatment for Parkinson’s Disease
Although severed peripheral neural axons re-establish functional synapses, in the central nervous system damaged axons fail to regenerate. This had been attributed to the lack of production in damaged brain of “neurotrophic substances” to support axonal growth1. During the last 20 years, however, there have been several important discoveries which have made possible serious attempts to promote repair from damage or degeneration in the central nervous system. An increasing number of studies have sought means for retarding degenerative neurological diseases or for replacing degenerated neurons, particularly in Parkinson’s disease.
KeywordsCaudate Nucleus Human Fetal Tissue Dopaminergic Innervation Tissue Implant Degenerative Neurological Disease
Unable to display preview. Download preview PDF.
- 1.Ramon, Y., Casal, S., 1928, Degeneration and regeneration of the nervous system, Vol. 2, R,M. May, ed., Oxford University Press, London.Google Scholar
- 11.Burns, R.W., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M. and Kopin, I.J., 1983, A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80: 4546–4550.PubMedCrossRefGoogle Scholar
- 13.Joyce, J.N., Marshall, J.F., Bankiewicz, K.S., Kopin, I.J. and Jacobowitz, D.M, 1986, Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D2 receptor density. Brain Res. 382: 360–364.PubMedCrossRefGoogle Scholar
- 14.Bankiewicz, K.S., Plunkett, R.J., Kopin, I.J., Jacobowitz, D.M.,London, W.T., and Oldfield, E.H., 1988, Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts, in: Progress in Brain Research, Vol. 78, D.M. Gash and J. R. Sladek, eds., Elsevier, Amsterdam.Google Scholar
- 16.Bankiewicz, K.S., Plunkett, R.J., Jacobowitz, D.M., Porrino, L., di Porzio, U., London, W.T., Kopin, I.J., and Oldfield, E.H., 1989, Recovery from MPTP-induced parkinsonism in primates after fetal mesencephalon implants: Histochemical and behavioral studies, J. Neurosurg., in press.Google Scholar
- 17.Palmatier, M.A., Plunkett, R.J. and Kopin, I.J. (1989), Soluble neurite promoting activity in fetal or term amnion. Soc. Neurosci., Abs. p. 1356.Google Scholar
- 18.Bankiewicz, K.S., Plunkett, R.J., Jacobowitz, D.M., Kopin, I.J., Cummins, A.C. and Oldfield, E.H., 1989, Behavioral recovery in MPTP-hemiparkinsonian monkeys after amnion implantation into the head of caudate nucleus. Rest. Neurol. and Neurosci., 1: 10.Google Scholar
- 19.Bankiewicz, K.S., Kopin, I.J., Palmatier, M.A., 1989, GAP-43 is a marker for growing fibers in the striatum of MPTP-treated monkeys. Soc. Neurosci., Abs. p. 319.Google Scholar